Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.

Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.

Eur J Pharmacol. 2011 Nov 1;669(1-3):38-44. doi: 10.1016/j.ejphar.2011.07.047. Epub 2011 Aug 19.

PMID:
21871878
2.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
3.

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.

Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.

Toxicol In Vitro. 2010 Sep;24(6):1474-81. doi: 10.1016/j.tiv.2010.07.020. Epub 2010 Jul 23.

PMID:
20656007
5.

Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.

Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.

J Cell Biochem. 2013 Aug;114(8):1890-900. doi: 10.1002/jcb.24533.

PMID:
23494858
7.

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.

J Pharm Pharmacol. 2004 Aug;56(8):1061-6.

PMID:
15285852
8.

Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.

Gao A, Liang H, Wang X, Zhang X, Jing M, Zhang J, Yan Y, Xiang W.

Eur J Pharmacol. 2011 Jun 1;659(2-3):108-13. doi: 10.1016/j.ejphar.2011.03.023. Epub 2011 Mar 31.

PMID:
21458446
9.

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.

Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.

Breast Cancer Res. 2001;3(4):253-63. Epub 2001 Apr 2.

10.

PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.

Peng H, Yuan X, Shi R, Wei X, Ren S, Yan C, Ding Y, Lin Y, Fan D, Yang M, Zhang Y, Xiong D.

Eur J Pharmacol. 2013 Oct 15;718(1-3):459-68. doi: 10.1016/j.ejphar.2013.07.038. Epub 2013 Jul 30.

PMID:
23911883
11.

Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.

Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.

J Pharm Pharmacol. 2007 Dec;59(12):1649-55.

PMID:
18053326
12.
13.

A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.

Xue P, Yang X, Liu Y, Xiong C, Ruan J.

Biomed Pharmacother. 2014 Oct;68(8):1049-56. doi: 10.1016/j.biopha.2014.10.004. Epub 2014 Oct 14.

PMID:
25455158
14.

[Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].

Chen LM, Li YF, Zhang X, Yan SL, Liang YJ, Fu LW.

Ai Zheng. 2005 Feb;24(2):189-93. Chinese.

PMID:
15694031
15.

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.

Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.

Cancer Gene Ther. 2009 Jan;16(1):65-72. doi: 10.1038/cgt.2008.58. Epub 2008 Jul 25.

PMID:
18654608
16.

Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.

Ma B, Chai S, Li N, To KK, Kan WL, Yang D, Lin G.

Int J Pharm. 2012 Mar 15;424(1-2):33-9. doi: 10.1016/j.ijpharm.2011.12.046. Epub 2012 Jan 2.

PMID:
22226881
17.

Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.

Ye W, Chang HL, Wang LS, Huang YW, Shu S, Dowd MK, Wan PJ, Sugimoto Y, Lin YC.

Anticancer Res. 2007 Jan-Feb;27(1A):107-16.

18.

Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.

Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.

Biomed Pharmacother. 2009 Mar;63(3):202-8. doi: 10.1016/j.biopha.2008.07.090. Epub 2008 Aug 28.

PMID:
18818047
19.

Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.

Xu D, Lu Q, Hu X.

Cancer Lett. 2006 Nov 18;243(2):274-80. Epub 2006 Jan 10.

PMID:
16406853
20.

[Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].

Huang C, Cao P, Xie Z, Zhu H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Apr;36(4):317-22. doi: 10.3969/j.issn.1672-7347.2011.04.007. Chinese.

Supplemental Content

Support Center